A study delineated that traditional cancer drugs such as 5-flurouracil, doxorubicin, and oxaliplatin were incapable of activating PUMA-mediated apoptosis in colorectal cancer cells, rendering patients with GOF mutation in p53 likely to be resistant to these drugs [47]. This evidence concerns the gene TP53 and colorectal cancer.